Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video)
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video)
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
CeriBell, Inc. (CBLL) Stock Analysis: Unveiling a 159.52% Potential Upside in the Healthcare Sector 12 September 2025
Definitive Healthcare Corp. (DH) Stock Analysis: Navigating the SaaS Healthcare Intelligence Market with a 9.87% Upside 12 September 2025
Nurix Therapeutics, Inc. (NRIX): Investor Outlook Reveals 224% Potential Upside in Biotech Sector 12 September 2025
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a Potential 256% Upside in Genetic Medicine 12 September 2025
Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a Potential 182.74% Upside in the Biotechnology Sector 12 September 2025
Verastem, Inc. (VSTM) Stock Analysis: Evaluating a 65.78% Potential Upside Amid Biotech Advances 12 September 2025
Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a 199% Potential Upside in the Healthcare Sector 12 September 2025
ArriVent BioPharma, Inc. (AVBP) Stock Report: Analyzing a Potential 108% Upside in the Biotechnology Sector 12 September 2025
Sana Biotechnology, Inc. (SANA) Stock Analysis: A 154.9% Potential Upside Awaits Investors 12 September 2025
Neuropace, Inc. (NPCE) Stock Analysis: Exploring a 67% Potential Upside in the Medical Device Sector 12 September 2025
InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 13.64% Potential Upside in Healthcare 12 September 2025
Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with a 59.70% Potential Upside 12 September 2025
Valneva SE (VALN) Stock Analysis: A 46% Potential Upside in the Biotechnology Sector 12 September 2025
Evolus, Inc. (EOLS) Stock Analysis: Exploring a 150% Potential Upside in the Aesthetic Market 12 September 2025
Community Health Systems, Inc. (CYH): Investor Outlook with a 16% Potential Upside Amidst Market Challenges 12 September 2025
Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 66.74% Potential Upside in the Biotech Sector 12 September 2025
Nutex Health Inc. (NUTX) Investor Outlook: Exploring a Robust 162.68% Upside Potential 12 September 2025
Anavex Life Sciences Corp. (AVXL): Investor Outlook Highlights 258% Potential Upside in Biotech Play 12 September 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Great Western Mining Corporation Copper-Tungsten Discovery Unveils Major Nevada Upside (Video) 30 October 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video) 28 October 2025
Gattaca: AI-Driven Growth, Strategic Focus and Why FY26 Could Be a Breakout Year (Video) 24 October 2025
Ilika plc Goliath Pilot Line Now Fully Operational, Paving the Road to Licensing Deals (Video) 22 October 2025
Berkeley Group posts £254 million profit and maintains strong cash position in interim results 10 December 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
